Navigation Links
High Doses of Common Painkillers May Raise Risk for Heart Trouble

WEDNESDAY, May 29 (HealthDay News) -- People who take high doses of common painkillers known as non-steroidal anti-inflammatory drugs (NSAIDs) face a greater risk for heart problems, a new analysis shows.

Although NSAIDs are used around the world to help people with inflammatory conditions, such as rheumatoid arthritis, a review of nearly 650 randomized trials found that taking either 2,400 milligrams (mg) of ibuprofen or 150 mg of diclofenac daily increased the risk of heart attacks, strokes and death by about one-third. The findings were published online May 29 in the journal The Lancet.

The study authors said, however, that the increased risk of heart attacks from individual NSAIDs is proportional to a patient's underlying risk for heart attacks. Since people with a history of heart problems or risk factors for heart disease are at greatest risk, they concluded that doctors should weigh that before prescribing a high-dose NSAID regimen for such a patient.

"While NSAIDs increase vascular and gastrointestinal risks to a varying extent, our analyses indicate that the effects of different regimens in particular patients can be predicted, which may help physicians choosing between alternative NSAID regimens to weigh up which type of NSAID is safest in different patients," study author Colin Baigent, from the Clinical Trial Service Unit and Epidemiological Studies Unit at the University of Oxford, in England, said in a journal news release.

One expert agreed with that assessment.

"Considering NSAIDs are some of the most commonly used medications and their increased risk of heart disease, stroke, heart failure and death is significant, this meta-analysis may help doctors in guiding patients [about] which NSAID -- and at what dose -- might be the safest for them," said Dr. Suzanne Steinbaum, a preventive cardiologist at Lenox Hill Hospital in New York City.

"Through this analysis, the size of the risk could be predicted for each patient, and better advice could be given," Steinbaum said. "Because NSAIDs sometimes are a crucial part of one's quality of life, the more we understand about dosing, duration and risk becomes important so we [can] determine which is the best choice, -- especially for patients with heart disease or those who are at risk."

This latest review, which examined the outcomes of more than 353,000 patients, found that for every 1,000 patients with a moderate risk for heart disease, three would have an avoidable heart attack after taking high doses of NSAIDs for one year. The researchers said one of these heart attacks would be fatal.

The review also revealed that NSAIDs double the risk for heart failure. People on high doses of NSAIDs also have a two to four times greater risk for bleeding ulcers or other significant upper gastrointestinal problems.

In a commentary published in The Lancet, Dr. Marie Griffin, of Vanderbilt University Medical Center, said: "The meta-analysis offers considerable certainty about ... major vascular risks of high doses of the most commonly prescribed NSAIDs, but leaves large gaps about risks associated with lower NSAID doses, longer durations of use and residual effects after stopping treatment."

Although the analysis uncovered an association between high doses of NSAIDs and an increased risk for heart troubles, it didn't necessarily prove a cause-and-effect relationship.

More information

The U.S. National Institutes of Health provides more information on NSAIDs.

-- Mary Elizabeth Dallas

SOURCE: Suzanne Steinbaum, M.D., preventive cardiologist, Lenox Hill Hospital, New York City; The Lancet, news release, May 29, 2013.

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Icahn School of Medicine at Mount Sinai and Bene Pharmachem Gmbh to Collaborate on Clinical Studies for Mucopolysaccaridoses
2. Study compares effectiveness of 2 vs. 3 doses of HPV vaccine for girls and young women
3. Zocor Side Effects Update: Bernstein Liebhard LLP Comments on New Study Linking Kidney Problems to High Doses of Zocor, Other Statins
4. Interactions between drugs can also be measured at lowest doses
5. Heartburn Meds May Often Be Taken for Too Long, at Too-High Doses
6. High Doses of Vitamin C May Raise Risk of Kidney Stones
7. Chemo Pills Effective, But Patients May Skip Doses
8. Philadelphia Malpractice Lawyers at Console & Hollawell Explore Negligence as Overdoses from Prescription Painkillers Now Kill More People than Heroin
9. As painkiller overdoses mount, researchers outline effective approaches to curb epidemic
10. Doctor Shopping Tied to Fatal Prescription Drug Overdoses
11. Higher but not lower doses of vitamin D are effective in fracture risk reduction in older adults
Post Your Comments:
Related Image:
High Doses of Common Painkillers May Raise Risk for Heart Trouble
(Date:11/27/2015)... ... 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces ... This is one of Joplin's most famous and beautiful concert posters. The concert was ... in Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's ...
(Date:11/26/2015)... MI (PRWEB) , ... November 26, 2015 , ... ... for substance abuse located in central Michigan, have come together on Thanksgiving Day ... specially produced video, available for viewing on the Serenity Point YouTube channel, patients ...
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
(Date:11/26/2015)... San Antonio, TX (PRWEB) , ... November 26, 2015 , ... ... accomplishment! On November 19, 2015, our surgeons performed their 6,000th free flap breast ... Ledoux , “We wake up every day excited to rebuild lives and it’s an ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology: